Role of endogenous nitric oxide (NO) and NO synthases in healing of indomethacin-induced intestinal ulcers in rats

Life Sciences

Volumn 80, Issue 4, 2007, Pages 329-336

  Takeuchi, Koji ^a   Hatazawa, Ryo ^a   Tanigami, Mayu ^a   Tanaka, Akiko ^a   Ohno, Ryoko ^a   Yokota, Aya ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Angiogenic response; Healing; Indomethacin induced intestinal ulcer; Nitric oxide (NO) NO synthases

Indexed keywords

AMINOGUANIDINE; CALCIUM ION; CARMINIC ACID; CONSTITUTIVE NITRIC OXIDE; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; INTESTINE ULCER; MALE; NONHUMAN; RAT; SPRAGUE DAWLEY RAT; STAINING; UPREGULATION; VASCULARIZATION; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ANIMALS; DISEASE MODELS, ANIMAL; DUODENAL ULCER; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GUANIDINES; INDOMETHACIN; INJECTIONS, SUBCUTANEOUS; INTESTINE, SMALL; ISOENZYMES; NEOVASCULARIZATION, PHYSIOLOGIC; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; WOUND HEALING;

ANIMALIA; RATTUS;

EID: 33845608141     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.09.016     Document Type: Article

References (38)

1. - secretion mediated by a common pathway: involvement of PG, NO and bradykinin. Journal of Physiology and Pharmacology 56 (2005) 391-406
2. Akiba Y., Nakamura M., Mori M., Suzuki H., Oda M., Kimura H., Miura S., Tsuchiya M., and Ishii H. Inhibition of inducible nitric oxide synthase delays gastric ulcer healing in the rats. Journal of Clinical Gastroenterology 27 Suppl 1 (1998) S64-S73
3. Araki H., Komoike Y., Matsumoto M., Tanaka A., and Takeuchi K. Healing of duodenal ulcers is not impaired by indomethacin or rofecoxib, the selective COX-2 inhibitor, in rats. Digestion 66 (2002) 145-153
4. Bredt D.S., Hwang P.M., Glatt C.J., Lowenstein C., Reed R.R., and Snyder S.H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351 (1991) 714-718
5. Brown J.F., Tepperman B.L., Hanson P.J., Whittle B.J.R., and Moncada S. Differential distribution of nitric oxide synthase between cell fractions isolated from the rat gastric mucosa. Biochemical and Biophysical Research Communication 184 (1992) 680-685
6. Feng L., Sun W., Xia Y., Tang W.W., Chanmugam P., Soyoola E., Wilson C.B., and Hwang D. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Archives of Biochemistry and Biophysics 307 (1993) 361-368
7. Furukawa O., Kitamura M., Sugamoto S., and Takeuchi K. Stimulatory effect of nitric oxide on bicarbonate secretion in bullfrog duodenums in vitro. Digestion 60 (1999) 324-331
8. Green L.C.D., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Analysis of nitrate, nitrite and 15N-nitrate in biological fluids. Analytical Biochemistry 126 (1982) 131-138
9. Griffiths M.J.D., Messent M., MacAllister R.J., and Evans T.W. Aminoguanidine selectively inhibits inducible nitric oxide synthase. British Journal of Pharmacology 110 (1993) 963-968
10. Hatazawa R., Ohno R., Tanigami M., Tanaka A., and Takeuchi K. Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats. Journal of Pharmacology and Experimental Therapeutics 18 (2006) 691-699
11. Hirata T., Ukawa H., Yamakuni H., Kato S., and Takeuchi K. Cyclooxygenase isozymes in acute mucosal ulcerogenic and functional responses following barrier disruption in rat stomachs. British Journal of Pharmacology 122 (1997) 447-454
12. Kato S., Tanaka A., Konaka A., Kunikata T., and Takeuchi K. Changes in gastric mucosal ulcerogenic responses in rats with adjuvant arthritis: role of nitric oxide. Alimental Pharmacology and Therapeutics 13 (1999) 833-840
13. Kimura M., Amemiya K., Tamada T., and Suzuki J. Quantitative method for measuring adjuvant-induced angiogenesis in insulin-treated diabetic mice. Journal of Pharmacobiodynamics 9 (1986) 442-446
14. Konaka A., Nishijima M., Tanaka A., Kato S., and Takeuchi K. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats. Journal of Physiology and Pharmacology 50 (1999) 25-38
15. Konturek S.J., Brzozowski T., Majka J., Polmczyk J., and Stachula J. Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. European Journal of Pharmacology 239 (1993) 215-217
16. Levi S., Goodlad R.A., Lee C.Y., Stamp G., Walport M.J., Wright N.A., and Hodgson H.J.F. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 336 (1990) 840-843
17. Lyons C.R., Orloff G.J., and Cunningham J.M. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. Journal of Biological Chemistry 267 (1992) 6370-6374
18. Ma L., and Wallace J.L. Endothelial nitric oxide synthase modulates gastric ulcer healing in rats. American Journal of Physiology 279 (2000) G341-G346
19. Matthews J.B., and Garner A. Review article: stomach wars: a mucosal defence initiative. Alimental Pharmacology and Therapeutics 5 (1991) 105-114
20. Mizuno H., Akamatsu T., and Kasuga M. Induction of cyclooxygenase-2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112 (1997) 387-397
21. Moncada S., Palmer R.M.J., and Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Phamacological Reviews 43 (1991) 109-142
22. Morbidelli L., Chang C.H., Douglas J.G., Granger H.J., Ledda F., and Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. American Journal of Physiology 270 (1996) H411-H415
23. Ohno R., Yokota A., Tanaka A., and Takeuchi K. Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric oxide synthase inhibitors. Journal of Pharmacology and Experimental Therapeutics 310 (2004) 821-827
24. Schmassmann A., Tarnawski A., Peskar B.M., Varga L., Flogerzi B., and Halter F. Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin. American Journal of Physiology 268 (1995) G276-G285
25. Takeeda M., Yamato M., Kato S., and Takeuchi K. Cyclooxygenase isozymes involved in adaptive functional responses in rat stomachs following barrier disruption. Journal of Pharmacology and Experimental Therapeutics 307 (2003) 713-719
26. Takeuchi K., Ueki S., and Tanaka H. Endogenous prostaglandins in gastric alkaline response in rat stomach after damage. American Journal Physiology 250 (1986) G842-G849
27. Takeuchi K., Ohuchi T., and Okabe S. Endogenous nitric oxide in gastric alkaline response in the rat stomach after damage. Gastroenterology 106 (1994) 367-374
28. Takeuchi K., Kato S., Takehara K., Asada Y., and Yasuhiro T. Role of nitric oxide in mucosal blood flow response and healing of HCl-induced lesions in rat stomachs. Digestion 58 (1997) 19-27
29. Tanaka A., Kunikata T., Konaka A., Kato S., and Takeuchi K. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats. Journal of Physiology and Pharmacology 50 (1999) 405-417
30. Tanaka A., Hase S., Miyazawa T., and Takeuchi K. Up-regulation of COX-2 by inhibition of COX-1: a key to NSAID-induced intestinal damage. Journal of Pharmacology and Experimental Therapeutics 300 (2002) 754-761
31. Tanaka A., Hase S., Ohno R., and Takeuchi K. Roles of COX-1 and COX-2 inhibition in NSAID-induced intestinal damage in rats. Journal of Pharmacology and Experimental Therapeutics 303 (2002) 1248-1254
32. Tarnawski A., Szabo I.L., Husain S.S., and Soreghan B. Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways. Journal of Physiology (Paris) 95 (2001) 337-344
33. Tso J.Y., Sun X.-H., Kao T.-H., Reece K.S., and Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Research 13 (1985) 2485-2502
34. Wallace J.L., McKnight W., and Reuter B.K. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroeneterology 119 (2000) 706-714
35. Wang J.Y., Yamasaki S., Takeuchi K., and Okabe S. Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin. Gastroenterology 96 (1989) 393-402
36. Whittle B.J.R., Laszlo F., Evans S.M., and Moncada S. Induction of nitric oxide synthase and injury in the rat jejunum provoked by indomethacin. British Journal of Pharmacology 116 (1995) 2286-2290
37. Yamamoto H., Tanaka A., Kunikata T., Hirata T., Kato S., and Takeuchi K. Inducible types of cyclooxygenase and nitric oxide synthase in adaptive cytoprotection in rat stomachs. Journal of Physiology (Paris) 93 (1999) 405-412
38. Ziche M., Morbidelli L., Choudhuri R., Zhang H.T., Donnini S., Granger H.J., and Bicknell R. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. Journal of Clinical Investigation 99 (1997) 2625-2634